According to Future Market Insights (FMI), the global bronchoscopes market is set to witness steady growth, with sales projected to reach USD 480.3 million by the end of 2021. The market is expected to expand at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period from 2022 to 2028, reaching an estimated USD 647.7 million in 2028.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), lung cancer, and bronchial infections, is a primary driver of market growth. Bronchoscopes, vital diagnostic and therapeutic tools, are becoming more widely adopted as healthcare providers focus on improving patient outcomes and early disease detection.
Advancements in bronchoscopy technology, including enhanced visualization and minimally invasive procedures, are also contributing to market expansion. The growing demand for flexible bronchoscopes, which offer better maneuverability and patient comfort, underscores the importance of innovation in this field.
Key Growth Drivers
The growth of the bronchoscopes market is influenced by several factors:
- Increasing Incidence of Respiratory Disorders: The rising prevalence of respiratory diseases, including lung cancer and chronic obstructive pulmonary disease (COPD), is driving demand for bronchoscopic procedures.
- Demand for Minimally Invasive Procedures: There is a growing preference for minimally invasive diagnostic and therapeutic procedures, which bronchoscopes facilitate effectively.
Market Dynamics
- The market is characterized by a variety of bronchoscope designs, including flexible and rigid types, each serving specific clinical needs.
- Innovations in technology, such as enhanced imaging capabilities and improved ergonomics, are contributing to market expansion.
Regional Insights
- North America is expected to lead the market due to advanced healthcare infrastructure and high rates of respiratory disease diagnoses.
- The Asia-Pacific region is anticipated to grow rapidly, driven by increasing healthcare investments and a rising burden of respiratory conditions.
Bronchoscopes Market – Competitive Landscape
Key manufacturers of the bronchoscopes market are focusing on gaining approvals from various regulatory authorities, expanding their business in new regions, and collaborating with other leading players in order to strengthen their product portfolio and market presence all over the world.
- In September 2021, Ambu A/S announced the European regulatory clearance, the CE mark for their combined product Ambu® aScope™ 4 Broncho Sampler Set, which is a combination of single-use bronchoscope and specimen sampling system, which was designed to conduct bronchial wash (BL) and Bronchoalveolar Lavage (BAL) procedures together with high efficiency, safety an improved workflow.
- In April 2021, Richard wolf GmbH announced the opening of their subsidiary in Madrid Spain, known as Richard Wold Endoscopia Ibérica S.L., in alignment of their efforts to be a globally active company.
- In May 2021, Hoya Corporation announced the technical collaboration with Hitachi, as a part of their five year contract, to expand their endoscopic portfolios and supply of diagnostic ultrasound systems and sensors.
The increasing demand for bronchoscopy procedures, higher prevalence rates of chronic pulmonary disorders will offer many opportunities for the key players.
A Comprehensive Full Report
Key Companies Profiled
Olympus Corporation; Fujifilm Holdings Corporation; Teleflex Incorporated; Karl Storz GmbH & Co KG; Richard Wolf GmbH; Hoya Corporation (Pentax medical); Ambu A/S; Shanghai AoHua Photoelectricity Endoscope Co. Ltd.; Rochling Group
Bronchoscopes Market, By Category
Product:
- Non-Video Bronchoscopes
- Video Bronchoscopes
Modality:
- Rigid Bronchoscopes
- Flexible Fiber Bronchoscopes
- Mobile Bronchoscopes
End User:
- Hospitals
- Outpatient Centers
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube